Lv1
46 积分 2022-08-11 加入
EGFR mutation and response of lung cancer to gefitinib
5小时前
待确认
Therapeutic targeting of RAS-mediated resistance in oncogene-driven lung cancer
1天前
已完结
Small-molecule activation of the tumor suppressor kinase LKB1 via the pseudokinase STRAD
2天前
已关闭
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
2天前
已完结
Farnesylation-driven KRAS phase separation promotes colon tumor growth
9天前
已完结
Selective Inhibition of KRASG13C Reveals an Increased Dependence on Wild-Type RAS Isoforms in Codon 13 RAS-Mutant Cancers
13天前
已完结
Targeting SHOC2: a treatable therapeutic site in RAS(Q61) mutant cancers
23天前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
24天前
已完结
Late Breaking Abstract - PMG1015 demonstrates well-tolerated safety and favorable FVC changes after 12 weeks of treatment in IPF Patients
24天前
已关闭
The design and synthesis of highly efficient FAK inhibitor for the potential treatment of colorectal cancer harboring KRAS mutation
24天前
已完结
皖公网安备34019202002308
